American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Opko Health Inc.

OPK Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

OPK historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of OPK by members of U.S. Congress

Politician Type Traded
Carlos Curbelo House / R Purchase $1,001 - $15,000 Sep 26, 2017
Carlos Curbelo House / R Purchase $1,001 - $15,000 Mar 02, 2017
Carlos Curbelo House / R Purchase $1,001 - $15,000 Feb 07, 2017
OPK Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
OPK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
OPK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in OPK holdings by institutional investors

Insider Trading

Quarterly net insider trading by OPK's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $45,000 Jul 15, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Pharmacy
  • $22,500 Apr 14, 2026 Issue: Health Issues
  • $17,000 Jan 06, 2025 Issue: Health Issues
  • $25,000 Oct 31, 2024 Issue: Health Issues
  • $25,000 Jul 30, 2024 Issue: Health Issues
  • $25,000 Feb 05, 2024 Issue: Health Issues
  • $25,000 Oct 02, 2023 Issue: Health Issues
  • $25,000 Aug 04, 2023 Issue: Health Issues
  • $50,000 Jan 08, 2023 Issue: Health Issues
  • $50,000 Nov 02, 2022 Issue: Health Issues
  • $50,000 Jul 07, 2022 Issue: Health Issues
  • $50,000 May 05, 2022 Issue: Health Issues
  • $50,000 Feb 09, 2022 Issue: Health Issues
  • $50,000 Nov 03, 2021 Issue: Health Issues
  • $50,000 Aug 05, 2021 Issue: Health Issues
  • $50,000 May 03, 2021 Issue: Health Issues
  • $50,000 Feb 03, 2021 Issue: Health Issues
  • $60,000 Nov 04, 2020 Issue: Health Issues
  • $50,000 Aug 05, 2020 Issue: Health Issues
  • $50,000 Apr 26, 2020 Issue: Health Issues
  • $50,000 Jan 23, 2020 Issue: Health Issues
  • $51,000 Nov 18, 2019 Issue: Health Issues
  • $37,000 Jul 30, 2019 Issue: Health Issues
  • $37,000 Jul 30, 2019 Issue: Health Issues
  • $25,000 Aug 17, 2016 Issue: Health Issues
  • $25,000 Jul 06, 2016 Issue: None
  • $36,000 Mar 31, 2015 Issue: Health Issues
  • $40,000 Jan 20, 2015 Issue: Health Issues Veterans Medicare/Medicaid
  • $45,000 Nov 16, 2014 Issue: Health Issues Veterans Government Issues
Revolving Door

Former government officials who have lobbied for OPK

2 former government officials at 1 lobbying firm have lobbied for OPK, most recently Feb 10, 2026.

  • Denny Salas Other New Executive VP Formerly Executive VP · GOTHAM GOVERNMENT RELATIONS · Feb 10, 2026
  • David Schwartz Other New President Formerly President · GOTHAM GOVERNMENT RELATIONS · Feb 10, 2026
Corporate Lobbying

OPK Estimated quarterly lobbying spending

Revenue Breakdown

OPK Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
OPK Income Statement
OPK Balance Sheet
OPK Cash Flow
U.S. Patents

New OPK patent grants

  • Patent Title: Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor Feb. 05, 2019
  • Patent Title: Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds Jun. 19, 2018
  • Patent Title: Nk May. 15, 2018
  • Patent Title: Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds Nov. 21, 2017
  • Patent Title: Nk Jun. 27, 2017
  • Patent Title: Nk Oct. 18, 2016
  • Patent Title: Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same May. 24, 2016
  • Patent Title: Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds Feb. 16, 2016
  • Patent Title: Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds Feb. 02, 2016
  • Patent Title: Intravenous formulations of neurokinin-1 antagonists Aug. 11, 2015
  • Patent Title: Hypersulfated disaccharide formulations Apr. 14, 2015
  • Patent Title: Nk1 antagonists Aug. 05, 2014
  • Patent Title: Nk1 antagonists Jun. 17, 2014
  • Patent Title: Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds Oct. 08, 2013
  • Patent Title: Hypersulfated disaccharide formulations Oct. 01, 2013
  • Patent Title: Hydrochloride salts of 8-[{1-(3,5-bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor Jun. 25, 2013
  • Patent Title: Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same Mar. 26, 2013
  • Patent Title: Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom Jan. 29, 2013
  • Patent Title: Nk Sep. 25, 2012
  • Patent Title: Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor May. 15, 2012
  • Patent Title: Nk Sep. 27, 2011
  • Patent Title: Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same Jul. 19, 2011
  • Patent Title: Nk Mar. 08, 2011
  • Patent Title: Nk1 antagonists May. 04, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to OPK from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
OPK News

Recent insights relating to OPK

CNBC Recommendations

Recent picks made for OPK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OPK

OPK Analyst Ratings

OPK Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
OPK Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $OPK stock a Buy, Sell, or Hold?

  • What is the price target for $OPK stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

OPK Top Shareholders
Shareholder
Shares Held
OPK Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $OPK stock?

  • Who owns the most shares of $OPK stock?

  • What funds own $OPK stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

OPK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view OPK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About OPK

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

  • Address Miami, FL
  • Market Cap 1.3 billion
  • Employees 2,275
  • Industrial Classification Pharmaceutical Preparations

Opko Health Inc. (OPK) Historical Stock Prices

Opko Health Inc. (OPK) closed at $1.70 on September 23, 2026. Over the past year its adjusted close ranged from $1.10 to $1.73. Daily prices go back to January 2, 2014, 3,196 trading days in all.

  • 1 month+14.86%
  • 3 months+14.09%
  • Year to date+34.92%
  • 1 year+18.06%
  • 3 years+4.94%
  • 5 years-54.67%
  • Max-79.79%
See every congressional and insider trade on the OPK price chart

Quiver Premium charts OPK's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 1.71 1.74 1.68 1.70 1.70 1,783,770
Sep 22, 2026 1.70 1.75 1.69 1.73 1.73 3,477,511
Sep 21, 2026 1.67 1.69 1.64 1.69 1.69 1,781,177
Sep 18, 2026 1.62 1.68 1.61 1.67 1.67 5,344,201
Sep 17, 2026 1.64 1.65 1.61 1.62 1.62 1,710,379
Sep 16, 2026 1.59 1.65 1.58 1.61 1.61 2,289,302
Sep 15, 2026 1.57 1.59 1.54 1.57 1.57 1,424,446
Sep 14, 2026 1.59 1.60 1.54 1.56 1.56 2,147,327
Sep 11, 2026 1.49 1.58 1.47 1.57 1.57 5,180,777
Sep 10, 2026 1.53 1.53 1.48 1.49 1.49 1,449,044
Sep 9, 2026 1.58 1.59 1.53 1.54 1.54 1,415,817
Sep 8, 2026 1.62 1.62 1.54 1.59 1.59 2,575,766
Sep 4, 2026 1.59 1.65 1.57 1.64 1.64 2,350,122
Sep 3, 2026 1.71 1.73 1.59 1.61 1.61 7,548,369
Sep 2, 2026 1.55 1.72 1.54 1.69 1.69 7,144,421
Sep 1, 2026 1.47 1.53 1.47 1.52 1.52 3,056,003
Aug 31, 2026 1.48 1.49 1.46 1.47 1.47 2,361,381
Aug 28, 2026 1.49 1.50 1.46 1.48 1.48 2,415,223
Aug 27, 2026 1.49 1.53 1.49 1.50 1.50 2,711,720
Aug 26, 2026 1.50 1.52 1.47 1.51 1.51 2,890,993
Aug 25, 2026 1.49 1.51 1.47 1.49 1.49 2,243,327
Aug 24, 2026 1.49 1.51 1.47 1.48 1.48 1,919,927
Aug 21, 2026 1.47 1.52 1.46 1.48 1.48 2,659,811
Aug 20, 2026 1.44 1.48 1.42 1.46 1.46 2,540,734
Aug 19, 2026 1.37 1.48 1.36 1.46 1.46 3,365,709
Aug 18, 2026 1.38 1.39 1.35 1.36 1.36 1,602,443
Aug 17, 2026 1.35 1.38 1.32 1.36 1.36 3,043,973
Aug 14, 2026 1.39 1.40 1.32 1.38 1.38 3,284,020
Aug 13, 2026 1.41 1.43 1.39 1.40 1.40 1,618,342
Aug 12, 2026 1.39 1.41 1.38 1.39 1.39 1,834,641
Aug 11, 2026 1.39 1.41 1.37 1.39 1.39 1,840,782
Aug 10, 2026 1.36 1.40 1.36 1.39 1.39 2,562,562
Aug 7, 2026 1.32 1.41 1.32 1.37 1.37 2,699,962
Aug 6, 2026 1.35 1.38 1.32 1.32 1.32 2,559,419
Aug 5, 2026 1.31 1.36 1.29 1.35 1.35 2,680,546
Aug 4, 2026 1.32 1.34 1.28 1.31 1.31 3,709,158
Aug 3, 2026 1.30 1.37 1.29 1.31 1.31 4,621,718
Jul 31, 2026 1.33 1.35 1.30 1.32 1.32 2,828,760
Jul 30, 2026 1.36 1.38 1.31 1.33 1.33 3,222,996
Jul 29, 2026 1.65 1.65 1.36 1.36 1.36 9,207,420
Jul 28, 2026 1.38 1.73 1.37 1.65 1.65 34,590,179
Jul 27, 2026 1.23 1.25 1.21 1.24 1.24 4,349,941
Jul 24, 2026 1.19 1.23 1.18 1.22 1.22 2,549,127
Jul 23, 2026 1.17 1.20 1.17 1.17 1.17 2,958,377
Jul 22, 2026 1.22 1.23 1.17 1.18 1.18 3,591,210
Jul 21, 2026 1.20 1.25 1.19 1.21 1.21 2,167,478
Jul 20, 2026 1.20 1.23 1.19 1.20 1.20 2,734,417
Jul 17, 2026 1.19 1.22 1.18 1.19 1.19 1,753,203
Jul 16, 2026 1.20 1.22 1.18 1.19 1.19 3,723,519
Jul 15, 2026 1.22 1.26 1.20 1.20 1.20 1,789,600
Jul 14, 2026 1.22 1.24 1.19 1.22 1.22 3,136,962
Jul 13, 2026 1.35 1.35 1.22 1.23 1.23 5,062,497
Jul 10, 2026 1.39 1.41 1.35 1.35 1.35 2,060,959
Jul 9, 2026 1.41 1.43 1.37 1.39 1.39 2,855,344
Jul 8, 2026 1.48 1.49 1.41 1.41 1.41 2,062,860
Jul 7, 2026 1.49 1.51 1.46 1.49 1.49 2,129,122
Jul 6, 2026 1.53 1.55 1.50 1.50 1.50 1,956,272
Jul 2, 2026 1.53 1.57 1.51 1.52 1.52 2,156,202
Jul 1, 2026 1.51 1.54 1.49 1.53 1.53 2,932,777
Jun 30, 2026 1.51 1.53 1.48 1.50 1.50 2,328,609
Jun 29, 2026 1.54 1.55 1.49 1.51 1.51 5,806,284
Jun 26, 2026 1.54 1.61 1.50 1.53 1.53 8,415,322
Jun 25, 2026 1.50 1.53 1.49 1.51 1.51 1,891,047
Jun 24, 2026 1.46 1.52 1.46 1.49 1.49 2,371,167
Jun 23, 2026 1.42 1.49 1.41 1.46 1.46 2,843,246
Jun 22, 2026 1.42 1.47 1.35 1.43 1.43 3,786,854
Jun 18, 2026 1.43 1.46 1.41 1.42 1.42 5,231,780
Jun 17, 2026 1.39 1.42 1.39 1.41 1.41 2,053,531
Jun 16, 2026 1.41 1.42 1.38 1.39 1.39 1,972,279
Jun 15, 2026 1.43 1.44 1.36 1.40 1.40 2,596,937
Jun 12, 2026 1.45 1.48 1.42 1.42 1.42 1,763,710
Jun 11, 2026 1.44 1.46 1.41 1.45 1.45 2,062,049
Jun 10, 2026 1.44 1.47 1.43 1.44 1.44 2,216,973
Jun 9, 2026 1.43 1.46 1.40 1.44 1.44 2,000,941
Jun 8, 2026 1.45 1.47 1.42 1.43 1.43 1,938,168
Jun 5, 2026 1.47 1.55 1.43 1.44 1.44 3,947,919
Jun 4, 2026 1.47 1.48 1.41 1.46 1.46 2,625,464
Jun 3, 2026 1.39 1.47 1.37 1.46 1.46 4,752,571
Jun 2, 2026 1.38 1.43 1.37 1.40 1.40 3,435,644
Jun 1, 2026 1.43 1.45 1.37 1.40 1.40 3,337,255
May 29, 2026 1.44 1.50 1.44 1.46 1.46 2,890,120
May 28, 2026 1.29 1.45 1.29 1.43 1.43 5,430,322
May 27, 2026 1.29 1.31 1.27 1.30 1.30 2,169,444
May 26, 2026 1.27 1.30 1.26 1.29 1.29 2,466,959
May 22, 2026 1.27 1.30 1.24 1.27 1.27 3,157,365
May 21, 2026 1.24 1.30 1.22 1.28 1.28 3,323,595
May 20, 2026 1.14 1.24 1.14 1.23 1.23 2,881,276
May 19, 2026 1.14 1.16 1.13 1.15 1.15 2,458,111
May 18, 2026 1.09 1.15 1.09 1.13 1.13 2,581,417
May 15, 2026 1.08 1.12 1.07 1.10 1.10 2,667,319
May 14, 2026 1.10 1.11 1.08 1.10 1.10 2,059,135
May 13, 2026 1.10 1.12 1.10 1.11 1.11 1,729,829
May 12, 2026 1.12 1.13 1.10 1.10 1.10 1,922,293
May 11, 2026 1.13 1.14 1.11 1.12 1.12 1,625,884
May 8, 2026 1.12 1.15 1.11 1.14 1.14 1,942,294
May 7, 2026 1.13 1.14 1.12 1.12 1.12 2,027,788
May 6, 2026 1.14 1.14 1.12 1.12 1.12 1,711,257
May 5, 2026 1.11 1.13 1.11 1.13 1.13 1,757,722
May 4, 2026 1.09 1.12 1.09 1.11 1.11 2,411,289
May 1, 2026 1.13 1.14 1.10 1.10 1.10 1,962,830
Apr 30, 2026 1.10 1.13 1.10 1.12 1.12 2,634,643
Apr 29, 2026 1.17 1.19 0.9769 1.11 1.11 10,115,698
Apr 28, 2026 1.20 1.22 1.20 1.21 1.21 1,523,378
Apr 27, 2026 1.20 1.22 1.20 1.20 1.20 1,368,929
Apr 24, 2026 1.22 1.25 1.21 1.23 1.23 1,818,345
Apr 23, 2026 1.23 1.26 1.22 1.22 1.22 1,516,436
Apr 22, 2026 1.22 1.26 1.22 1.23 1.23 1,637,892
Apr 21, 2026 1.23 1.25 1.21 1.22 1.22 1,499,768
Apr 20, 2026 1.22 1.23 1.20 1.22 1.22 1,399,002
Apr 17, 2026 1.23 1.25 1.21 1.24 1.24 1,604,797
Apr 16, 2026 1.17 1.22 1.16 1.21 1.21 4,433,901
Apr 15, 2026 1.16 1.19 1.16 1.18 1.18 1,101,788
Apr 14, 2026 1.17 1.19 1.17 1.17 1.17 1,593,622
Apr 13, 2026 1.16 1.18 1.14 1.17 1.17 2,776,122
Apr 10, 2026 1.17 1.17 1.14 1.16 1.16 1,479,788
Apr 9, 2026 1.17 1.20 1.17 1.17 1.17 1,440,624
Apr 8, 2026 1.20 1.22 1.19 1.19 1.19 2,916,973
Apr 7, 2026 1.17 1.19 1.16 1.17 1.17 1,927,168
Apr 6, 2026 1.13 1.20 1.13 1.18 1.18 2,715,952
Apr 2, 2026 1.12 1.15 1.11 1.14 1.14 1,157,826
Apr 1, 2026 1.16 1.16 1.13 1.13 1.13 1,615,382
Mar 31, 2026 1.11 1.15 1.11 1.14 1.14 2,573,532
Mar 30, 2026 1.13 1.13 1.09 1.10 1.10 2,681,529
Mar 27, 2026 1.15 1.18 1.11 1.12 1.12 3,472,936
Mar 26, 2026 1.18 1.19 1.15 1.17 1.17 2,617,692
Mar 25, 2026 1.14 1.20 1.14 1.19 1.19 3,426,623
Mar 24, 2026 1.14 1.16 1.12 1.13 1.13 3,527,500
Mar 23, 2026 1.12 1.16 1.11 1.15 1.15 4,482,580
Mar 20, 2026 1.16 1.18 1.10 1.12 1.12 4,522,222
Mar 19, 2026 1.16 1.18 1.15 1.17 1.17 2,775,267
Mar 18, 2026 1.19 1.21 1.17 1.17 1.17 2,801,183
Mar 17, 2026 1.20 1.21 1.19 1.19 1.19 1,826,441
Mar 16, 2026 1.20 1.22 1.18 1.19 1.19 2,357,280
Mar 13, 2026 1.16 1.20 1.16 1.19 1.19 2,272,417
Mar 12, 2026 1.14 1.18 1.14 1.16 1.16 2,834,211
Mar 11, 2026 1.17 1.19 1.16 1.16 1.16 1,683,549
Mar 10, 2026 1.20 1.22 1.18 1.19 1.19 1,727,436
Mar 9, 2026 1.15 1.22 1.15 1.21 1.21 2,051,995
Mar 6, 2026 1.16 1.19 1.15 1.18 1.18 2,568,005
Mar 5, 2026 1.19 1.21 1.16 1.17 1.17 2,405,894
Mar 4, 2026 1.21 1.22 1.19 1.20 1.20 1,430,777
Mar 3, 2026 1.21 1.22 1.16 1.19 1.19 3,361,749
Mar 2, 2026 1.19 1.25 1.18 1.24 1.24 2,650,771
Feb 27, 2026 1.19 1.26 1.19 1.20 1.20 3,827,025
Feb 26, 2026 1.19 1.20 1.16 1.20 1.20 2,144,097
Feb 25, 2026 1.15 1.20 1.14 1.18 1.18 2,452,589
Feb 24, 2026 1.15 1.16 1.13 1.15 1.15 2,280,606
Feb 23, 2026 1.19 1.21 1.15 1.15 1.15 2,133,792
Feb 20, 2026 1.20 1.22 1.19 1.20 1.20 1,308,466
Feb 19, 2026 1.21 1.21 1.19 1.21 1.21 1,326,622
Feb 18, 2026 1.21 1.23 1.20 1.22 1.22 1,489,442
Feb 17, 2026 1.23 1.24 1.21 1.22 1.22 1,307,465
Feb 13, 2026 1.22 1.27 1.21 1.23 1.23 2,144,684
Feb 12, 2026 1.25 1.25 1.20 1.21 1.21 2,174,741
Feb 11, 2026 1.24 1.25 1.22 1.25 1.25 1,567,436
Feb 10, 2026 1.22 1.25 1.21 1.22 1.22 1,443,149
Feb 9, 2026 1.24 1.25 1.21 1.22 1.22 2,096,112
Feb 6, 2026 1.24 1.25 1.23 1.24 1.24 3,384,661
Feb 5, 2026 1.25 1.26 1.23 1.23 1.23 4,180,381
Feb 4, 2026 1.27 1.28 1.25 1.25 1.25 3,344,999
Feb 3, 2026 1.27 1.30 1.25 1.26 1.26 2,058,339
Feb 2, 2026 1.25 1.31 1.25 1.28 1.28 6,599,192
Jan 30, 2026 1.25 1.27 1.24 1.26 1.26 4,149,839
Jan 29, 2026 1.27 1.29 1.24 1.27 1.27 3,713,136
Jan 28, 2026 1.29 1.32 1.26 1.28 1.28 4,527,206
Jan 27, 2026 1.30 1.31 1.27 1.29 1.29 1,613,482
Jan 26, 2026 1.31 1.33 1.28 1.30 1.30 6,255,650
Jan 23, 2026 1.36 1.37 1.31 1.32 1.32 966,036
Jan 22, 2026 1.39 1.43 1.36 1.36 1.36 3,018,661
Jan 21, 2026 1.29 1.38 1.27 1.38 1.38 6,683,070
Jan 20, 2026 1.26 1.32 1.25 1.29 1.29 3,705,670
Jan 16, 2026 1.28 1.30 1.27 1.28 1.28 2,374,129
Jan 15, 2026 1.30 1.31 1.27 1.28 1.28 1,698,756
Jan 14, 2026 1.35 1.35 1.27 1.30 1.30 2,756,991
Jan 13, 2026 1.32 1.34 1.31 1.34 1.34 4,237,705
Jan 12, 2026 1.36 1.36 1.31 1.33 1.33 1,969,806
Jan 9, 2026 1.37 1.37 1.34 1.36 1.36 2,493,234
Jan 8, 2026 1.35 1.38 1.34 1.37 1.37 2,432,249
Jan 7, 2026 1.33 1.37 1.31 1.36 1.36 3,140,496
Jan 6, 2026 1.27 1.32 1.27 1.32 1.32 2,756,086
Jan 5, 2026 1.27 1.29 1.24 1.28 1.28 5,223,337
Jan 2, 2026 1.26 1.33 1.25 1.27 1.27 4,736,286
Dec 31, 2025 1.29 1.30 1.25 1.26 1.26 4,949,045
Dec 30, 2025 1.29 1.31 1.26 1.30 1.30 6,985,777
Dec 29, 2025 1.28 1.34 1.26 1.29 1.29 5,647,557
Dec 26, 2025 1.30 1.30 1.27 1.29 1.29 2,297,272
Dec 24, 2025 1.30 1.32 1.29 1.30 1.30 1,870,655
Dec 23, 2025 1.32 1.33 1.29 1.31 1.31 2,295,395
Dec 22, 2025 1.30 1.37 1.29 1.33 1.33 3,758,257
Dec 19, 2025 1.30 1.33 1.30 1.31 1.31 5,716,545
Dec 18, 2025 1.32 1.32 1.30 1.31 1.31 3,227,720
Dec 17, 2025 1.31 1.33 1.29 1.31 1.31 3,519,691
Dec 16, 2025 1.36 1.38 1.30 1.31 1.31 6,577,573
Dec 15, 2025 1.38 1.39 1.34 1.35 1.35 5,302,507
Dec 12, 2025 1.39 1.42 1.35 1.38 1.38 2,784,452
Dec 11, 2025 1.38 1.39 1.36 1.39 1.39 2,444,740
Dec 10, 2025 1.36 1.39 1.33 1.37 1.37 2,912,937
Dec 9, 2025 1.31 1.38 1.30 1.36 1.36 3,562,179
Dec 8, 2025 1.34 1.35 1.28 1.32 1.32 5,113,464
Dec 5, 2025 1.33 1.36 1.33 1.34 1.34 1,394,474
Dec 4, 2025 1.36 1.37 1.33 1.35 1.35 1,282,082
Dec 3, 2025 1.33 1.37 1.32 1.37 1.37 2,986,031
Dec 2, 2025 1.31 1.36 1.30 1.33 1.33 2,730,070
Dec 1, 2025 1.34 1.35 1.30 1.32 1.32 2,745,122
Nov 28, 2025 1.35 1.36 1.33 1.36 1.36 1,115,665
Nov 26, 2025 1.33 1.36 1.33 1.34 1.34 1,518,399
Nov 25, 2025 1.30 1.36 1.29 1.35 1.35 2,716,533
Nov 24, 2025 1.32 1.34 1.29 1.30 1.30 5,267,397
Nov 21, 2025 1.30 1.34 1.29 1.32 1.32 3,299,681
Nov 20, 2025 1.32 1.35 1.29 1.30 1.30 3,798,164
Nov 19, 2025 1.28 1.32 1.27 1.31 1.31 2,520,991
Nov 18, 2025 1.25 1.29 1.24 1.28 1.28 2,383,871
Nov 17, 2025 1.27 1.29 1.25 1.27 1.27 3,343,605
Nov 14, 2025 1.26 1.30 1.25 1.28 1.28 2,637,649
Nov 13, 2025 1.32 1.33 1.27 1.28 1.28 2,235,537
Nov 12, 2025 1.34 1.36 1.30 1.32 1.32 2,087,802
Nov 11, 2025 1.34 1.35 1.22 1.33 1.33 3,314,243
Nov 10, 2025 1.35 1.38 1.32 1.33 1.33 1,721,789
Nov 7, 2025 1.38 1.39 1.32 1.34 1.34 3,038,808
Nov 6, 2025 1.35 1.40 1.30 1.38 1.38 3,913,766
Nov 5, 2025 1.38 1.40 1.34 1.34 1.34 2,457,385
Nov 4, 2025 1.37 1.43 1.37 1.39 1.39 2,716,014
Nov 3, 2025 1.37 1.43 1.36 1.40 1.40 3,269,634
Oct 31, 2025 1.42 1.44 1.35 1.36 1.36 3,978,691
Oct 30, 2025 1.40 1.50 1.40 1.46 1.46 2,297,938
Oct 29, 2025 1.44 1.47 1.41 1.43 1.43 2,541,885
Oct 28, 2025 1.45 1.47 1.43 1.44 1.44 1,234,550
Oct 27, 2025 1.50 1.51 1.44 1.45 1.45 1,272,493
Oct 24, 2025 1.53 1.54 1.49 1.50 1.50 1,227,507
Oct 23, 2025 1.50 1.52 1.49 1.52 1.52 1,081,462
Oct 22, 2025 1.49 1.51 1.46 1.51 1.51 2,255,508
Oct 21, 2025 1.52 1.53 1.48 1.48 1.48 1,330,513
Oct 20, 2025 1.54 1.55 1.52 1.53 1.53 1,821,347
Oct 17, 2025 1.50 1.52 1.49 1.52 1.52 1,573,534
Oct 16, 2025 1.53 1.56 1.50 1.50 1.50 1,345,114
Oct 15, 2025 1.52 1.53 1.50 1.52 1.52 1,517,826
Oct 14, 2025 1.49 1.53 1.48 1.52 1.52 1,243,071
Oct 13, 2025 1.53 1.54 1.49 1.51 1.51 1,294,432
Oct 10, 2025 1.56 1.57 1.50 1.51 1.51 2,050,987
Oct 9, 2025 1.55 1.56 1.54 1.56 1.56 1,390,564
Oct 8, 2025 1.54 1.57 1.53 1.55 1.55 1,781,212
Oct 7, 2025 1.58 1.59 1.54 1.54 1.54 1,516,957
Oct 6, 2025 1.57 1.60 1.55 1.58 1.58 1,404,542
Oct 3, 2025 1.54 1.59 1.54 1.56 1.56 1,717,355
Oct 2, 2025 1.55 1.56 1.51 1.54 1.54 2,001,848
Oct 1, 2025 1.52 1.57 1.52 1.55 1.55 2,238,010
Sep 30, 2025 1.47 1.55 1.47 1.55 1.55 2,516,834
Sep 29, 2025 1.46 1.50 1.44 1.47 1.47 2,643,192
Sep 26, 2025 1.43 1.47 1.41 1.45 1.45 2,112,872
Sep 25, 2025 1.47 1.48 1.43 1.43 1.43 1,936,240
Sep 24, 2025 1.45 1.49 1.42 1.48 1.48 2,675,687
Sep 23, 2025 1.44 1.48 1.41 1.44 1.44 2,327,989

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Opko Health Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at OPK, per a recent SEC DEF 14A filing. We estimate that the median employee at OPKO HEALTH, INC. is paid $45,683.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation